月期刊平台服务过的文章录用时间为1-3个月，依据20年经验，经月期刊专家预审通过后的文章，投稿通过率100%以上！
由《Bentham Science》出版社出版。ISSN: 1568 - 0096。《当前癌症药物靶标》旨在涵盖药物化学、药理学、分子生物学、基因组学和当代癌症分子药物靶标生物化学(如疾病特异性蛋白、受体、酶、基因)的所有最新和杰出的发展。该杂志的每一期都包含了一系列由该领域的领导者撰写的及时深入的评论，涵盖了与癌症有关的药物靶点的一系列当前主题。随着用于抗癌药物发现的新型人类药物靶点的发现、鉴定、表征和验证的不断增长;这本杂志将是所有参与药物发现和开发的药物学家的必读书。
http://bsp-cms.eurekaselect.com/index.php/CCDT
Published by Bentham Science Publishers. ISSN: 1568-0096.Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer. As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.
